Minjie Luo

2.6k total citations
65 papers, 1.0k citations indexed

About

Minjie Luo is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Minjie Luo has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Genetics and 18 papers in Cancer Research. Recurrent topics in Minjie Luo's work include Genomic variations and chromosomal abnormalities (12 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic factors in colorectal cancer (8 papers). Minjie Luo is often cited by papers focused on Genomic variations and chromosomal abnormalities (12 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic factors in colorectal cancer (8 papers). Minjie Luo collaborates with scholars based in United States, China and United Kingdom. Minjie Luo's co-authors include Lisa Edelmann, Ruth Kornreich, Stuart A. Scott, Robert J. Desnick, Laura K. Conlin, Maode Lai, Liu Liu, Ramakrishnan Rajagopalan, Marilyn M. Li and Lina Shao and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Minjie Luo

60 papers receiving 1000 citations

Peers

Minjie Luo
George Jarad United States
Guo-Hua Fong United States
Patricia L. St. John United States
Martin P. Powers United States
Xiaohe Cai United States
Shao-Qing Kuang United States
George Jarad United States
Minjie Luo
Citations per year, relative to Minjie Luo Minjie Luo (= 1×) peers George Jarad

Countries citing papers authored by Minjie Luo

Since Specialization
Citations

This map shows the geographic impact of Minjie Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Luo more than expected).

Fields of papers citing papers by Minjie Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjie Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Luo. The network helps show where Minjie Luo may publish in the future.

Co-authorship network of co-authors of Minjie Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Minjie Luo. A scholar is included among the top collaborators of Minjie Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjie Luo. Minjie Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhenyu, Ziming Wang, Jingsheng Huang, et al.. (2025). EMP1-driven ferroptosis in liver sinusoidal endothelial cells exacerbates hepatic ischemia-reperfusion injury via P38 MAPK. Free Radical Biology and Medicine. 244. 186–196.
2.
Deng, Yu‐Hao, et al.. (2024). Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics. Genes Chromosomes and Cancer. 63(4). e23233–e23233. 1 indexed citations
3.
Ryan, Anne L., Daniel Wong, Minjie Luo, et al.. (2024). Keratin-Positive Giant Cell Tumor of Bone and Soft Tissue With HMGA2::NCOR2 Fusion in Children Under 10 With Response to Imatinib Therapy: A Case Series. JCO Precision Oncology. 8(8). e2300659–e2300659.
4.
Luo, Minjie, Derek Wong, Kristin Zelley, et al.. (2024). Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence. JNCI Journal of the National Cancer Institute. 116(8). 1356–1365. 2 indexed citations
5.
Luo, Minjie, et al.. (2024). Roles of prostaglandins in immunosuppression. Clinical Immunology. 265. 110298–110298. 8 indexed citations
6.
Lebo, Matthew S., Marcie Steeves, Laura K. Conlin, et al.. (2023). O31: Risk allele evidence curation, classification, and reporting: Recommendations from the ClinGen Low Penetrance/Risk Allele Working Group*. SHILAP Revista de lepidopterología. 1(1). 100457–100457. 3 indexed citations
7.
Chen, Jiani, Jinhua Wu, Fumin Lin, et al.. (2023). The spectrum of RAF1 fusion positive solid tumors in children and young adults.. Journal of Clinical Oncology. 41(16_suppl). e22013–e22013. 1 indexed citations
8.
Feng, Yun, Shujie Huang, Siyuan Lv, et al.. (2022). Teriparatide induces angiogenesis in ischemic cerebral infarction zones of rats through AC/PKA signaling and reduces ischemia-reperfusion injury. Biomedicine & Pharmacotherapy. 148. 112728–112728. 11 indexed citations
9.
Liu, Jiale, Minjie Luo, Siyuan Lv, et al.. (2022). Case Report: Reversible Hyperglycemia Following Rapamycin Treatment for Atypical Choroid Plexus Papilloma in an Infant. Frontiers in Endocrinology. 13. 865913–865913.
10.
Ross, Justyne, Bing Zhang, Kristy Lee, et al.. (2021). Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Blood Advances. 5(2). 414–431. 22 indexed citations
11.
Akkari, Yassmine, Hélène Bruyèrè, R. Tanner Hagelstrom, et al.. (2020). Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia. Cancer Genetics. 243. 52–72. 14 indexed citations
12.
Jung, Hou-Sung, Fumin Lin, Adam J. Wolpaw, et al.. (2020). A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma. Cancer Genetics. 246-247. 41–43. 4 indexed citations
13.
Neill, Stewart G., Marilyn M. Li, Yajuan J. Liu, et al.. (2020). Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors. Cancer Genetics. 243. 19–47. 3 indexed citations
14.
Guan, Qiaoning, Jorune Balciuniene, Kajia Cao, et al.. (2018). AUDIOME: a tiered exome sequencing–based comprehensive gene panel for the diagnosis of heterogeneous nonsyndromic sensorineural hearing loss. Genetics in Medicine. 20(12). 1600–1608. 27 indexed citations
15.
Bhoj, Elizabeth, Zhenming Yu, Qiaoning Guan, et al.. (2016). Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing. Genetics in Medicine. 19(6). 715–718. 14 indexed citations
16.
Mulchandani, Surabhi, Elizabeth Bhoj, Minjie Luo, et al.. (2015). Maternal uniparental disomy of chromosome 20: a novel imprinting disorder of growth failure. Genetics in Medicine. 18(4). 309–315. 73 indexed citations
17.
Huang, Shuyun, Chanjuan Wang, Xinlin Sun, et al.. (2014). Krüppel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21. Cancer Letters. 356(2). 547–555. 30 indexed citations
18.
Scott, Stuart A., Lisa Edelmann, Liu Liu, et al.. (2010). Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Human Mutation. 31(11). 1240–1250. 115 indexed citations
19.
Li, Honghua, Hui‐Yun Wang, Danielle M. Greenawalt, et al.. (2009). Identification of possible genetic alterations in the breast cancer cell line MCF-7 using high-density SNP genotyping microarray. Journal of Carcinogenesis. 8(1). 6–6. 6 indexed citations
20.
Hu, Guohong, Hui‐Yun Wang, Danielle M. Greenawalt, et al.. (2006). AccuTyping: new algorithms for automated analysis of data from high-throughput genotyping with oligonucleotide microarrays. Nucleic Acids Research. 34(17). e116–e116. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026